Company Active LTD

Company profile

Apeikon Therapeutics Ltd

apeikon.com

This domain name has been registered with Gandi.net. It is currently parked by the owner.

CRN
13057597
Founded
2020
Age
5

Overview

Legal name
APEIKON THERAPEUTICS LTD
Region
London
Registered address
71-75 SHELTON STREET
COVENT GARDEN
LONDON
UNITED KINGDOM
WC2H 9JQ
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

8 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

09 Dec
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

25 Nov
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

22 Nov
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQ0NDU5MDIxOGFkaXF6a2N4

Published 22 Nov 2024 12:31

22 Nov
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQ0NDU5MDIxM2FkaXF6a2N4

Published 22 Nov 2024 12:31

29 Oct
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ0MTIyMzY2MmFkaXF6a2N4

Published 29 Oct 2024 09:07

02 Dec
2020

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2022
Funded years
2022
Age at first award
1 years

Projects

2022 Collaborative R&D Lead participant

Image-guided, focused ultrasound-triggered drug delivery technology for brain cancers

1 Jun 2022 to 31 May 2024

Awarded
£258,826
Total cost £369,752

Life-saving cancer treatment comes with many side effects that impact patients' quality of life, often for significant periods of time. Patients also suffer clinical signs such as liver or kidney toxicity, reduced immune function that increases risk of infection and even internal bleeding. This exerts a heavy cost on the National Health Service, related t...

Product types

Collaborative R&D